Vaccitech Co-Founder Professor Adrian Hill on Developing a Covid-19 Vaccine

Dec 4, 2020

Following the news that AstraZeneca, the University of Oxford, and Vaccitech’s vaccine for COVID-19 is highly effective and safe, Vaccitech co-founder Professor Adrian Hill talked to Tom Hulme, General Partner at Vaccitech shareholder GV, Vidu Shanmugarajah, Partner at GV and Vaccitech Board Observer, and GV’s portfolio CEOs about the battle against the pandemic.

Here Adrian recounts the story behind his search for a vaccine, results from late-stage clinical trials, the challenges of manufacturing and global distribution — and what has to happen next to stop the virus.

The original video and post from Tom Hulme can be found on the GV website at the following link.